A retrospective cohort study evaluating safety of telaprevir in combination with pegylated interferon-alfa-2b and ribavirin in patients with genotype 1 chronic hepatitis C
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions
Most Recent Events
- 25 Jan 2018 New trial record